National Cancer Institute, Amended Notice of Meeting, 32672 [07-2902]

Download as PDF 32672 Federal Register / Vol. 72, No. 113 / Wednesday, June 13, 2007 / Notices The burden estimate for the electronic reporting of adverse events is based on the number of facilities currently participating in MedSun (400) and the number of sites (50) expected to be added to the program over the next 3 years. The current average number of reports per site is 7 reports annually. For purposes of this renewed data collection, we are estimating an average of 15 reports per site annually. This increase is expected since MedSun is working to promote reporting in general from the sites, as well as promoting reporting from specific parts of the hospitals, such as the pediatric intensive care units, electrophysiology laboratories, and the hospital laboratories. Therefore, this yields a total annual responses of 6,000 (400 facilities x 15 data entries = 6,000.) The participating MedSun reporters tell FDA that it typically takes 20 to 45 minutes to fill out the online form. Using the high end of that timeframe, the overall annual burden hours will be 4,500 hours (6,000 report entries x 0.75 hours = 4,500 hours). Determining burden for the DS–X portion of MedSun: Not all sites use this part of the software. To determine the total annual responses for DS–X: 200 participants multiplied by the number of times each will access DS–X yields annual responses of 1,000 reports. It typically takes an average of 30 minutes to enter data into DS–X, given that there are various types of data entries which are possible, some of which are lengthier than others. The number of burden hours for DS–X is determined by multiplying the expected 1,000 times the site will be accessed by the average amount of time it takes to make a DS–X data entry (30 minutes). This equals a burden of 500 hours (1,000 x 0.50 = 500). The total burden hours for MedSun and DS–X data entry equals 8,000 hours (7,500 for MedSun and 500 for DS–X). Dated: June 7, 2007. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. E7–11400 Filed 6–12–07; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES sroberts on PROD1PC70 with NOTICES National Institutes of Health National Cancer Institute, Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Advisory Board, June 14, 2007, 1:15 VerDate Aug<31>2005 18:30 Jun 12, 2007 Jkt 211001 p.m. to June 15, 2007, 11:45 a.m. National Institutes of Health, Building 31, 31 Center Drive, Bethesda, MD 20892 which was published in the Federal Register on May 21, 2007, 72 FR 28512. This notice is amended to add the NCAB Ad Hoc Subcommittee on Experimental Therapeutics meeting on June 14, 2007 from 8:30 p.m. to 10:30 p.m. at the Bethesda Hyatt Hotel, One Metro Center, Bethesda, MD 20814. The meeting is open to the public. Dated: June 6, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–2902 Filed 6–12–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center on Minority Health and Health Disparities; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center on Minority Health and Health Disparities Special Emphasis Panel; Research Infrastructure in Minority Institutions (RIMI) Meeting. Date: July 22–24, 2007. Time: 5 p.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015. Contact Person: Robert Nettey, MD, Scientific Review Administrator, National Institute on Minority Health and Health Disparities, 6707 Democracy Blvd., Suite 800, Bethesda, MD 20892, (301) 496–3996. PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 Dated: June 6, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–2903 Filed 6–12–07; 8:45 am] BILLING CODE: 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel, Autism Centers Review. Date: July 9, 2007. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Vinod Charles, PhD, Scientific Review Administrator, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6151, MSC 9606, Bethesda, MD 20892–9606, 301–443–1606. Name of Committee: National Institute of Mental Health Special Emphasis Panel, Disaster Mental Health Centers Review. Date: July 26, 2007. Time: 10 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Marina Broitman, PhD, Scientific Review Administrator, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6153, MSC 9608, Bethesda, MD 20892–9608, 301–402–8152, mbroitma@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development E:\FR\FM\13JNN1.SGM 13JNN1

Agencies

[Federal Register Volume 72, Number 113 (Wednesday, June 13, 2007)]
[Notices]
[Page 32672]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-2902]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute, Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Cancer Advisory Board, June 14, 2007, 1:15 p.m. to June 15, 2007, 11:45 
a.m. National Institutes of Health, Building 31, 31 Center Drive, 
Bethesda, MD 20892 which was published in the Federal Register on May 
21, 2007, 72 FR 28512.
    This notice is amended to add the NCAB Ad Hoc Subcommittee on 
Experimental Therapeutics meeting on June 14, 2007 from 8:30 p.m. to 
10:30 p.m. at the Bethesda Hyatt Hotel, One Metro Center, Bethesda, MD 
20814. The meeting is open to the public.

    Dated: June 6, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-2902 Filed 6-12-07; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.